Trademarkia Logo

Canada

C$
Trademark Search in Canada
KYVERNA

View On IC.GC.CA

KYVERNA
APPROVED

on 6 Feb 2025

Last Applicant/ Owned by

Kyverna Therapeutics, Inc.

5980 Horton StreetSuite 550Emeryville, CA 94608

US

Serial Number

2019025 filed on 23rd Mar 2020

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

KYVERNA

Trademark usage description

pharmaceutical therapeutics for the treatment of autoimmune diseases; pharmaceutical therapeutics and cell therapy products in the nature of cells for Read More

Classification Information

Class [005]
Pharmaceutical therapeutics for the treatment of autoimmune diseases; pharmaceutical therapeutics and cell therapy products in the nature of cells for medical and clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical and clinical use for the treatment of autoimmune disease

Classification kind code

11

Class [042]
Medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease

Classification kind code

11

Class [044]
Medical services for the diagnosis and treatment of autoimmune disease; medical services, namely, Chimera Antigen Receptor Therapy ("CAR-T")

Classification kind code

11

Mark Details

Serial Number

2019025

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 6th Feb 2025		Approved
Submitted for opposition 27
on 6th Feb 2025		Approval Notice Sent
Submitted for opposition 22
on 21st Jun 2024		Search Recorded
Submitted for opposition 20
on 21st Jun 2024		Examiner's First Report
Submitted for opposition 287
on 8th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 135
on 11th May 2021		Amendment to Application
Submitted for opposition 30
on 23rd Mar 2020		Filed
Submitted for opposition 1
on 23rd Mar 2020		Created
Submitted for opposition 31
on 23rd Mar 2020		Formalized